Transforming growth factor-β inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 4022-4027

  Casey, M Linette ^a,b   Macdonald, Paul C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; MEMBRANE METALLOENDOPEPTIDASE; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; DECIDUALIZATION; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; ENDOMETRIUM CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELLS, CULTURED; DECIDUA; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HALF-LIFE; HUMANS; LUTEAL PHASE; MEDROXYPROGESTERONE 17-ACETATE; NEPRILYSIN; PREGNANCY; PROGESTERONE; PROGESTERONE CONGENERS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029798293     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.4022     Document Type: Article

References (37)

1. Casey ML, Smith JW, Nagai K, Hersh LB, MacDonald PC. 1991 Progesterone-regulated cyclic modulation of membrane metalloendopeptidase (enkephalinase) in human endometrium. J Biol Chem. 266:23041-23047.
2. Lotkowski G, Zijderhand-Bleekemolen JE, Erdös EG, Von Figura K, Hasilik A. 1987 Neutral endopeptidase-24.11 (enkephalinase). Biosynthesis and localization in human fibroblasts. Biochem J. 248:345-350.
3. Head JR, MacDonald PC, Casey ML. 1993 Cellular localization of membrane metalloendopeptidase (enkephalinase) in human endometrium during the ovarian cycle. J Clin Endocrinol Metab. 76:769-776.
4. Casey ML, Smith JW, Nagai K, MacDonald PC. 1993 Transforming growth factor-β1 inhibits enkephalinase (EC 3.4.24.11) gene expression in human endometrial stromal cells and sex skin fibroblasts in culture. J Clin Endocrinol Metab. 77:144-150.
5. Machida CM, Muldoon LL, Rodland KD, Magun BE. 1988 Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor-β. Mol Cell Biol. 8:2479-2483.
6. Edwards DR, Murphy G, Reynold JJ, et al. 1987 Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1899-1904.
7. Kerr LD, Miller DB, Matrisian LM. 1990 TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell. 61:267-278.
8. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. 1988 A nuclear factor 1 binding site mediates the transcriptional activation of collagen promoter by transforming growth factor-β. Cell. 52:405-414.
9. Bell SC. 1990 Decidualization and relevance to menstruation. In: d'Arcangues C, Fraser IS, Newton JR, Odlind V. eds. Contraception and mechanisms of endometrial bleeding. Cambridge: Cambridge University Press; 187-209.
10. Tamada H, McMaster MT, Flanders KC, Andrews GK, Dey SK. 1990 Cell type-specific expression of transforming growth factor-β1 in the mouse uterus during the periimplantation period. Mol Endocrinol. 4:965-972.
11. Borson DB, Gruenert DC. 1991 Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol. 260:L83-L89.
12. Strahle U, Boshart M, Klock G, Stewart F, Schultz G. 1989 Glucocorticoid- and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature. 339:629-632.
13. D'Adamio L, Shipp MA, Masteller EL, Reinherz EL. 1989 Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5X-untranslated regions. Proc Natl Acad Sci USA. 86:7103.
14. Petrocelli T, Lye SJ. 1993 Regulation of transcripts encoding the myometrial gap junction protein, connexin-43, by estrogen and progesterone. Endocrinology. 133:284-290.
15. Lau TM, Gow CB, Fairclough RJ. 1992 Increases in the oxytocin-induced prostaglandin F2 alpha response and reduction in the concentrations of endometrial oxytocin receptors in ewes in response to progesterone. J Reprod Fertil. 95:11-18.
16. Vallet JL, Lamming GE, Batten M. 1990 Control of endometrial oxytocin receptor and uterine response to oxytocin by progesterone and oestradiol in the ewe. J Reprod Fertil. 90:625-634.
17. Zhang J, Weston PG, Hixon JE. 1992 Role of progesterone and oestradiol in the regulation of uterine oxytocin receptors in ewes. J Reprod Fertil. 94:395-404.
18. Johannisson E. 1990 Endometrial morphology during the normal cycle and under the influence of contraceptive steroids. In: d'Arcangues C, Fraser IS, Newton JR, Odlind V. eds. Contraception and mechanisms of endometrial bleeding. Cambridge: Cambridge University Press; 53-72.
19. Sporn MB, Roberts AB. 1989 Transforming growth factor-β: multiple actions and potential clinical applications. JAMA. 262:938-941.
20. Marbaix E, Donnex J, Courtoy PJ, Eeckhout Y. 1992 Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA. 89:11789-11793.
21. Hamilton JA, Wojta J, Gallichio M, McGrath K, Filonzi EL. 1993 Contrasting effects of transforming growth factor-β and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J Immunol. 151:5154-5161.
22. Schatz F, Lockwood CJ. 1993 Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab. 77:621-625.
23. Ranganathan G, Blatti SP, Subramaniam M, Fass DN, Maihle NJ, Getz MJ. 1991 Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type-β1. J Biol Chem. 266:496-501.
24. Lockwood CJ, Nemerson Y, Guller S, et al. 1993 Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab. 76:231-236.
25. Arici A, MacDonald PC, Casey ML. Modulation of the levels of interleukin-8 mRNA and interleukin-8 protein synthesis in human endometrial stromal cells by transforming growth factor-β1. J Clin Endocrinol Metab. In press.
26. Kerr LD, Olashaw NE, Matrisian LM. 1988 Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J Biol Chem. 263:16999-17005.
27. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN. 1995 Transforming growth factor-beta inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Commun. 215:386-393.
28. Murata J, Corradin SB, Felley-Bosco E, Juillerat-Jeanneret L. 1995 Involvement of a transforming-growth-factor-beta-like molecule in tumor-cell-derived inhibition of nitric-oxide synthesis in cerebral endothelial cells. Int J Cancer. 62:743-748.
29. Rainey WE, Naville D, Saez J, et al. 1990 Transforming growth factor beta (TGF-β) inhibits steroid 17α-hydroxylase cytochrome P-450 gene expression in ovine adrenocortical cells. Endocrinology. 127:1910-1915.
30. Sordoillet C, Chauvin MA, Hendrick JC, Franchimont P, Morera AM, Benahmed M. 1992 Sites of interaction between epidermal growth factor and transforming growth factor-beta 1 in the control of steroidogenesis in cultured porcine Leydig cells. Endocrinology. 130:1352-1358.
31. Stankovic AK, Dion LD, Parker CR, Jr. 1994 Effects of transforming growth factor-beta on human fetal adrenal steroid production. Mol Cell Endocrinol. 99:145-151.
32. Engelhardt H, Tekpetey FR, Gore-Langton RE, Armstrong DT. 1992 Regulation of steroid production in cultured porcine thecal cells by transforming growth factor-beta. Mol Cell Endocrinol. 85:117-126.
33. Yanagisawa M, Kurihara N, Kimura S. 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:411-415.
34. 2α. J Clin Endocrinol Metab. 75:1027-1032.
35. Economos K, MacDonald PC, Casey ML. 1992 Endothelin-1 gene expression and protein biosynthesis in human endometrium: potential modulator of endometrial blood flow. J Clin Endocrinol Metab. 74:14-19.
36. Salamonsen LA, Butt AR, Macpherson AM, Rogers PAW, Findlay JK. 1992 Immunolocalization of the vasoconstrictor endothelin in human endometrium during the menstrual cycle and in umbilical cord at birth. Am J Obstet Gynecol. 167:163-167.
37. Cameron IT, Davenport AP, van Papendorp C, et al. 1992 Endothelin-like immunoreactivity in human endometrium. J Reprod Fertil. 95:623-628.